tirzepatide and increased heart rate Effects of on the Clinical Trajectory of Patients With Failure, Preserved Ejection Fraction, Obesity Exacerbation of Postural Orthostatic Tachycardia

As a dual receptor agonist, Tirzepatide targets both GLP-1 and GIP receptors, a mechanism distinct from single-pathway GLP-1 medications, supporting appetite control, insulin sensitivity, and weight reduction

The reduction of cardiovascular disease does not decrease medical claims to the point where it is more financially beneficial to include the GLP-1s on the drug formularies because the claims resulting from the medication alone are higher than the claims related to cardiovascular treatments

DMPS is effective in accelerating metal excretion without severe adverse effects in acute and chronic intoxication by inorganic and organic mercury, bismuth, arsenic, and chronic lead poisoning

Esto importa porque el vaciamiento gstrico retrasado puede aumentar el riesgo de aspiracin

While the number of cases is small, they suggest that more research is needed, especially in women who are still menstruating

Response: We thank the commenter for their comment